Summit Cancer Centers-Post Falls — Post Falls, Idaho

Summit Cancer Centers-Post Falls is a clinical research site located in Post Falls, Idaho, United States 83854.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Summit Cancer Centers-Post Falls has participated in 1 clinical trials.

Therapeutic areas: High Grade Sarcoma, Metastatic Leiomyosarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Summit Cancer Centers-Post Falls?

Summit Cancer Centers-Post Falls has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Summit Cancer Centers-Post Falls conducted?

Summit Cancer Centers-Post Falls has 1 clinical trials on record. Their work covers High Grade Sarcoma, Metastatic Leiomyosarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor.

Is Summit Cancer Centers-Post Falls accredited by Crixeo Health?

Summit Cancer Centers-Post Falls has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Summit Cancer Centers-Post Falls?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.